Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Computacenter reports record year but warns of challenging 2024

(Sharecast News) - Computacenter delivered another record year of revenues and adjusted profits with gross invoiced income topping the £10bn mark, but said that trading conditions at the start of this year are likely to be challenging. The tech services company said it expects to make "further progress" in 2024, though growth will be weighted to the second half, "reflecting a significantly more challenging comparison in the first half".

Gross invoiced income rose 11.4% to £10.08bn in 2023, driven by strong growth in the Technology Sourcing division, helping group revenues to rise 7% to £6.92bn.

Adjusted pre-tax profit was up a lesser 5.4% at £278m, with adjusted earnings per share rising 3% to 174.8p, which the firm put down to doubled levels of investment in strategic initiatives to "improve our capabilities, enhance productivity and secure future growth".

Computacenter proposed a final dividend of 47.4p, increasing the full-year payout by 3.1% to 70p.

"We delivered our nineteenth consecutive year of growth in adjusted earnings per share, outperforming our markets in 2023, as our large customers continued to invest heavily in new technology," said chief executive Mike Norris.

"We managed an uncertain macroeconomic backdrop and inflationary pressures effectively, reduced our inventory significantly, resulting in a record net cash position. As planned, we stepped up our investment in strategic initiatives to underpin our competitiveness and future growth."

As for 2024, the company said volumes in Technology Sourcing will likely normalise as some of the high-volume, lower-margin projects delivered, especially in the first half of 2023, were completed.

Share this article

Related Sharecast Articles

Biome Technologies shares sink as Q1 sales drop 44%
(Sharecast News) - Shares in AIM-listed Biome Technologies plummeted by almost a third on Monday after the bioplastics and radio frequency technology business reported a poor start to the year with first-quarter sales dropping by 44%.
Entain reprices two term loans, revises interest cost outlook
(Sharecast News) - Betting and gambling giant Entain announced the successful repricing of two of its existing 'Term Loan B' loans on Monday, along with the pricing and allocation of fungible add-ons, in a bid to optimise its financial position.
Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.